Pharmacy Management

Pharmacy Management

Prescription drugs are the fastest growing component of healthcare costs. These costs can be prohibitive, requiring employers to change plan designs and shift even more cost to their employees. This is particularly true for specialty medications that typically represent 50% of drug spend from just 1-2% of drug utilizers. 

Unfortunately, many employers don’t have the purchasing power or market leverage to negotiate better pricing. It’s also challenging for employers to identify and access money saving opportunities. 

Our Alera Group Pharmacy Solutions practice has a dedicated team of experienced, in-house Pharmacy Benefits Management experts. They offer a full range of pharmacy consulting services, including:

  • Prescription drug program evaluations for clients of all sizes and industries
  • Comprehensive RFP management renewal, market check and RFI
  • PBM contract review and negotiation
  • Consultative support to identify and deploy unique cost-mitigation for specialty drug solutions
  • Data analytics that enable precise financial and clinical pharmacy benefits consulting and reporting, maximizing the plan value and employee dollars
  • All forms of pharmacy benefits auditing, including PBM contract pricing, plan design and clinical
  • On-going risk management and cost containment under our Rx Concierge Program

With Alera Group, you have a local partner and a team of experts you can rely on to help you manage pharmacy costs and improve your outcomes today and in the future.

Our Alera Group Pharmacy Solutions experts are backed by leading-edge tools and strategic solutions focused on meeting the needs and expectations of our clients through every stage of the pharmacy process.

Control pharmacy costs

From procurement to prescriptions.

Report Image
Download Now

Find an office or contact us

EXPERT EDUCATION

Events and Webinars

Employee Benefits

2025 Healthcare and Employee Benefits Benchmarking Report: How Does Your Benefits Program Stack Up?

In this session, our experts will dive into the results of our annual, market-leading benchmarking survey.

June 26, 2025 at 01:00 pm CT | Virtual

Sign Up
Engage Webinar Graphic

Employee Benefits

Dynamic Data: Strategies for Success

Join us for this session, as our experts will share how to utilize your organization’s data to create advanced and innovative strategies for success.

July 17, 2025 at 01:00 pm CT | Virtual

Sign Up
Webinar Graphic

Employee Benefits

Preparing for Open Enrollment: How to Engage and Educate Your Employees on Their Total Benefits Package

In this session, our experts will share guidance on setting yourself up for success during Open Enrollment.

August 21, 2025 at 01:00 pm CT | Virtual

Sign Up
Webinar Graphic

THOUGHT LEADERSHIP

Insights

Employee Benefits

Benchmarking: How Do Your Organization’s Employee Benefits Offerings Stack Up?

For the sixth consecutive year, Alera Group is offering a valuable piece of market intelligence: our Healthcare and Employee Benefits Benchmarking Report. We’ll introduce the 2025 edition on its release date, June 26, with a one-hour webinar beginning at 1 p.m. CT.

June 5, 2025

Find out more

Employee Benefits

​​​​​Reminder: PCORI Fees Due By July 31, 2025

Employers that sponsor self-insured group health plans, including health reimbursement arrangements (HRAs) should keep in mind the upcoming July 31, 2025 deadline for paying fees that fund the Patient-Centered Outcomes Research Institute (PCORI) via Form 720, which was recently updated and released by the IRS.

June 3, 2025

Find out more

Employee Benefits

Legal Alert: RxDC Reporting Due June 1

Reminder: RxDC Reporting Due June 1

With the 2023 reference year RxDC reporting deadline approaching soon, plan sponsors should familiarize themselves with recent updates to the RxDC Reporting Instructions.

March 27, 2024

Find out more

Employee Benefits

Webinar: Weight-Loss Drugs and Group Health Plans | Alera Group

Rising pharmacy costs are among the chief drivers of healthcare expenses for employers and employees, thanks largely to a surge in use of drugs you’ve seen advertised in those ubiquitous commercials. Given the cost of such drugs and their mixed record of success, employers and employees should exercise caution.

February 6, 2024

Find out more